npj Vaccines研究:强制新冠疫苗政策未引发其他疫苗接种率下降
Mandates without backlash: COVID-19 vaccine policies and the uptake of other vaccines
一项发表于npj Vaccines的研究利用全球国家-年份面板数据,结合牛津政府响应追踪数据,评估了强制新冠疫苗政策对HPV、流感及常规儿童疫苗接种率的影响。研究采用de Chaisemartin and D’Haultfoeuille动态平均处理效应估计量,发现采纳强制疫苗政策后,其他疫苗的国家覆盖率未出现系统性下降,但部分常规儿童疫苗的前置趋势差异需谨慎解读。
- Article
- Open access
- Published: 06 October 2026
npj Vaccines (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
This paper examines whether mandatory COVID-19 vaccination policies generated spillover effects on the uptake of other vaccines. Using a global country-year panel, we combine COVID-19 vaccine mandate data from the Oxford COVID-19 Government Response Tracker with international vaccination coverage data for discretionary vaccines, including Human Papillomavirus (HPV) and Influenza, and routine childhood vaccines, including Measles-containing, Rubella-containing, Diphtheria-Tetanus-Pertussis (DTP)-containing, Polio-containing, Haemophilus influenzae type b (Hib)-containing, Hepatitis B-containing, Rotavirus-containing, and Pneumococcal-containing vaccines. The treatment is measured by a binary indicator that equals 1 if a country adopted any COVID-19 vaccine mandate. To address staggered mandate adoption and treatment effect heterogeneity across countries, we estimate dynamic average treatment effects for switching countries using the de Chaisemartin and D’Haultfoeuille (2026) staggered difference-in-differences estimator. Overall, we find no systematic evidence of declines in national coverage rates for other vaccines following COVID-19 vaccine mandate adoption. This is true for almost all vaccines studied. However, for some routine childhood vaccines, evidence of differential pre-treatment trends warrants caution in interpreting those estimates as definitive evidence of no causal effect. Power and sensitivity analyses show that, for seven routine outcomes, first-period declines can be excluded under moderate departures from parallel trends.
Acknowledgements
We are grateful to Alberto Soto Aladro for his help in the data collection. The research lab of Mohammad Abu-Zaineh and Bruno Ventelou has received funding from the French government under the “France 2030” investment plan managed by the French National Research Agency (Reference: ANR-17-EURE-0020) and from Excellence Initiative of Aix-Marseille University - A*MIDEX.
Author information
Authors and Affiliations
School of Economics, Administration, and Public Policy, Doha Institute for Graduate Studies, Doha, Qatar
Sahar F. Yousef
Aix-Marseille Univ, CNRS AMSE, Marseille, France
Mohammad Abu-Zaineh & Bruno Ventelou
Faculty of Medical and Paramedical Sciences of Aix-Marseille University, Marseille, France
Mohammad Abu-Zaineh
Observatoire Régional de la Santé (ORS) Paca, Southeastern Health Regional Observatory, Marseille, France
Pierre Verger
Unité des Virus Émergents (UVE: Aix-Marseille Université, Università di Corsica, IRD 190, Inserm 1207 IRBA), Marseille, France
Pierre Verger
Authors
- Sahar F. Yousef
- Mohammad Abu-Zaineh
- Pierre Verger
- Bruno Ventelou
Corresponding author
Correspondence to Mohammad Abu-Zaineh.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yousef, S.F., Abu-Zaineh, M., Verger, P. et al. Mandates without backlash: COVID-19 vaccine policies and the uptake of other vaccines. npj Vaccines (2026). https://doi.org/10.1038/s41541-026-01597-4
Received: 08 June 2026
Accepted: 22 September 2026
Published: 06 October 2026
DOI: https://doi.org/10.1038/s41541-026-01597-4
来源:Nature 健康护理主题 · nature.com